NHE1 mediates migration and invasion of HeLa cells via regulating the expression and localization of MT1-MMP

Cell Biochemistry and Function

Volumn 30, Issue 1, 2012, Pages 41-46

  Lin, Yani ^a   Wang, Jian ^a   Jin, Weina ^a   Wang, Lihong ^a   Li, Huawen ^a   Ma, Li ^a   Li, Qinghua ^a   Pang, Tianxiang ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Cervical cancer; Invasion; Localization; Membrane type 1 matrix metalloproteinase; Migration; Na + H + exchanger 1

Indexed keywords

CARIPORIDE; MATRIX METALLOPROTEINASE; MEMBRANE ANCHORED TYPE 1 MATRIX METALLOPROTEINASE; MESSENGER RNA; SODIUM PROTON EXCHANGE PROTEIN 1; UNCLASSIFIED DRUG; CATION TRANSPORT PROTEIN; GUANIDINE DERIVATIVE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITOR; MMP14 PROTEIN, HUMAN; SLC9A1 PROTEIN, HUMAN; SODIUM PROTON EXCHANGE PROTEIN; SULFONE;

ARTICLE; CANCER INVASION; CELL MIGRATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; GENETICS; HELA CELL LINE; METABOLISM; METASTASIS; PATHOLOGY; TUMOR INVASION; UTERINE CERVIX TUMOR;

CATION TRANSPORT PROTEINS; CELL MOVEMENT; CELL SURVIVAL; FEMALE; GUANIDINES; HELA CELLS; HUMANS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE INHIBITORS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; SODIUM-HYDROGEN ANTIPORTER; SULFONES; UTERINE CERVICAL NEOPLASMS;

EID: 84855310010     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1815     Document Type: Article

References (26)

1. Shen XY, Wang SH, Liang ML, Wang HB, Xiao L, Wang ZH. The role and mechanism of CXCR4 and its ligand SDF-1 in the development of cervical cancer metastasis. Ai Zheng 2008; 27: 316-319.
2. Hu X, Schwarz JK, Lewis JS, Jr, et al. A microRNA expression signature for cervical cancer prognosis. Cancer Res 2010; 70(4): 1441-1448.
3. Gillies RJ, Raghunand N, Karczmar GS, Bhujwalla ZM. MRI of the tumor microenvironment. J Magn Reson Imaging 2002; 16: 430-450.
4. + exchangers of mammalian cells. J Biol Chem 1997; 272: 22373-22376.
5. + exchanger in metastasis. Nat Rev Cancer 2005; 5: 786-795.
6. + exchanger 1 by RNA interference or amiloride inhibits human hepatoma cell line SMMC-7721 cell invasion. Med Oncol 2010; 28(1): 385-390.
7. + exchangers and RhoA regulate acidic extracellular pH-induced lysosome trafficking in prostate cancer cells. Traffic 2009; 10(6): 737-753.
8. + exchanger NHE1 by post-translational regulation that is important for cervical cancer cell invasiveness. J Cell Physiol 2008; 214(3): 810-819.
9. + exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J Biol Chem 2004; 279(26): 26991-27007.
10. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141(1): 52-67.
11. Itoh Y, Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 2006; 206(1): 1-8.
12. Kajita M, Itoh Y, Chiba T, et al. Membrane-type 1 matrix metalloprotease cleaves CD44 and promotes cell migration. J Cell Biol 2001; 153: 893-904.
13. Deryugina EI, Ratnikov BI, Postnova TI, Rozanov DV, Strongin AY. Processing of integrin alpha (v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J Biol Chem 2002; 277(12): 9749-9756.
14. Overall CM. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol Biotechnol 2002; 22(1): 51-86.
15. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2(3): 161-174.
16. Gilles C, Polette M, Piette J, et al. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 1996; 65: 209-213.
17. Mori H, Tomari T, Koshikawa N, et al. CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J 2002; 21(15): 3949-3959.
18. Chen WT, Wang JY. Specialized surface protrusions of invasive cells, invadopodia and lamellipodia, have differential MT1-MMP, MMP-2, and TIMP-2 localization. Ann N Y Acad Sci 1999; 878: 361-371.
19. Seiki M, Yana I. Roles of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Sci 2003; 94: 569-574.
20. Kato Y, Lambert CA, Colige AC, et al. Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signaling. J Biol Chem 2005; 208: 10938-10944.
21. + exchanger 1 by 5-(N-ethyl-N-isopropyl) amiloride reduces hypoxia-induced hepatocellular carcinoma invasion and motility. Cancer Lett 2010; 295(2): 198-204.
22. Gingras D, Beliveau R. Emerging concepts in the regulation of membrane-type 1 matrix metalloproteinase activity. Biochim Biophys Acta 2010; 1803(1): 142-150.
23. Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett 2003; 194(1): 1-11.
24. Linder S. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol 2007; 17: 107-117.
25. Sun XL, Li YZ, Yu WD, Wang B, Tao YX, Dai ZH. MT1-MMP as a downstream target of BCR-ABL/ABL interaction 1 signaling: polarized distribution and involvement in BCR-ABL-stimulated leukemic cell migration. Leukemia 2008; 22(5): 1053-1056.
26. + exchanger NHE1. J Cell Sci 2000; 113: 3649-3662.